Albiglutide Fragment GSK716155 Naliglutide CAS 782500-75-8
- Малатия Себастия
- 25/11/2024 11:59
Компания
-
Название компании
Albiglutide Fragment GSK716155 Naliglutide CAS 782500-75-8
-
Рабочая область
Здравоохранение, Фармацевтика
-
График
-
Образование
-
Опыт
Name Albiglutide
Chemical Name ((8-glycine)human glucagon-like peptide 1-(7-36)-peptidyl)((8-glycine)human glucagon-like peptide 1-(7-36)-peptidyl)(human serum albumin (585 residues));
Synonyms Albugon; Eperzan; Tanzeum™; Naliglutide; GSK716155; HSDB 8282; UNII-5E7U48495E;
Molecular Formula C3232H5032N864O979S41
Molecular Weight 72970.00000
CAS Number 782500-75-8
Albiglutide Fragment is a fragment of the soybean trypsin inhibitor, which is a protein that has been found to inhibit the activity of pancreatic enzymes. The fragment was designed to be used in diagnosis and treatment of infectious diseases. Albiglutide Fragment binds to the glucagon-like peptide (GLP) receptors on cells in the intestine and pancreas, inhibiting the production of pro-inflammatory cytokines and reducing inflammation. When it is bound to GLP receptors, albiglutide fragment blocks cell signals that lead to diabetes, obesity, and metabolic syndrome. Albiglutide Fragment can also be used as a contrast agent for imaging techniques such as magnetic resonance imaging or ultrasound. It binds to cells in high concentrations and can help visualize profiles of these cells. -
Пол
-
Возраст
-
Описание
-
Name Albiglutide
Chemical Name ((8-glycine)human glucagon-like peptide 1-(7-36)-peptidyl)((8-glycine)human glucagon-like peptide 1-(7-36)-peptidyl)(human serum albumin (585 residues));
Synonyms Albugon; Eperzan; Tanzeum™; Naliglutide; GSK716155; HSDB 8282; UNII-5E7U48495E;
Molecular Formula C3232H5032N864O979S41
Molecular Weight 72970.00000
CAS Number 782500-75-8
Albiglutide Fragment is a fragment of the soybean trypsin inhibitor, which is a protein that has been found to inhibit the activity of pancreatic enzymes. The fragment was designed to be used in diagnosis and treatment of infectious diseases. Albiglutide Fragment binds to the glucagon-like peptide (GLP) receptors on cells in the intestine and pancreas, inhibiting the production of pro-inflammatory cytokines and reducing inflammation. When it is bound to GLP receptors, albiglutide fragment blocks cell signals that lead to diabetes, obesity, and metabolic syndrome. Albiglutide Fragment can also be used as a contrast agent for imaging techniques such as magnetic resonance imaging or ultrasound. It binds to cells in high concentrations and can help visualize profiles of these cells.
